CLOVER HEALTH INVESTMENTS CORP DE

For the period ended Dec 31, 2024. Filed Mar 3, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 3, 2025

CLOV$4.83+0.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Clover Health Investments, Corp.
Date: March 3, 2025	By:	/s/ Andrew Toy
		Andrew Toy
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Andrew Toy
Signature	Title	Date
/s/ Andrew Toy	Chief Executive Officer (Principal Executive Officer) and Director	Date: March 3, 2025
/s/ Peter Kuipers	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)	Date: March 3, 2025
Peter Kuipers
/s/ Vivek Garipalli	Director and Executive Chair	Date: March 3, 2025
Vivek Garipalli
/s/ Chelsea Clinton	Director	Date: March 3, 2025
Chelsea Clinton
/s/ Demetrios L. Kouzoukas	Director	Date: March 3, 2025
Demetrios L. Kouzoukas
/s/ Lee A. Shapiro	Director	Date: March 3, 2025
Lee A. Shapiro
/s/ William G. Robinson, Jr.	Director	Date: March 3, 2025
William G. Robinson, Jr.
/s/ Carladenise A. Edwards	Director	Date: March 3, 2025
Carladenise A. Edwards
/s/ Anna U. Loengard	Director	Date: March 3, 2025
Anna U. Loengard
/s/ Thomas L. Tran	Director	Date: March 3, 2025
Thomas L. Tran

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.